Protect your family from pertussis. Learn about pertussis symptoms, treatment, and prevention. The Filipino version of this infographic can be accessed here.
To go to the convention site, please click here.
PSMID is pleased to share the newest SPOTLIGHTS features of the Philippines and Malaysia highlighting the unique Network structures of the two newest QIS+D countries from Southeast Asia.
PSMID is part of a national collaboration with the Sustained Health Initiatives of the Philippines (SHIP) to reduce HIV-related stigma and discrimination in healthcare settings.
The current algorithms are based on the best evidence available in scientific literature at the time of its formulation. However, these algorithms are not a comprehensive guide to all practice questions and management options on COVID-19. This is not meant to restrict the practitioner in using sound clinical judgement and sharing the decision with the patient, and from considering other management options according to the patient’s particular needs and preferences. The algorithms can serve to inform policy, but are not meant to serve as a basis for approving or denying financial coverage or insurance claims merely because of nonconformance with recommendations. Neither are the recommendations supposed to be considered as legal rules for dictating certain modes of action to the exclusion of others.
Last updated February 21, 2022.
The Unified COVID-19 Algorithms reflect evidence updates from the Philippine COVID-19 Living Recommendations. Version 4 is now subsumed under the Philippine COVID-19 Living Recommendations initiative in order to streamline the alignment of evidence with decision-making tools. Under this, it is funded by the Department of Health (DOH) AHEAD Program through the DOST-Philippine Council for Health Research and Development (PCHRD) and the DOH-Disease Prevention and Control Bureau (DPCB).
Version 4 is built on the grassroots effort of volunteers from different medical organizations, subject matter experts, stakeholders, as well as end-users. Facilitation was done by technical specialists from the Asia- Pacific Center for Evidence-Based Healthcare (APCEBH), Alliance for Improving Health Outcomes (AIHO), and Kalusugan ng Mag-Ina (KMI). With the Philippine context in perspective, the algorithms provide clear guidance for COVID-19 management from both the community and hospital levels. The development process was framed on evidence-based, patient-centered, and equity-driven principles.
Work on the first release of the Unified COVID-19 Algorithms started as early as March 2020 with representatives from the Philippine Society for Microbiology and Infectious Diseases (PSMID), Philippine College of Physicians (PCP), Philippine Society of General Internal Medicine (PSGIM), and the Philippine Society of Public Health Physicians (PSPHP). The Philippine College of Occupational Medicine (PCOM) and the Philippine College of Emergency Medicine (PCEM) were also among the first medical societies to join us in unifying guidance for colleagues at the frontlines. This collaboration incubated the formation of the Healthcare Professionals Alliance Against COVID-19 (HPAAC).
With continued support from PSMID, expansion was carried out by the HPAAC Steering Committee through its network of volunteers and the leadership of various medical professional societies. Major changes in the latest version include the following:
These algorithms are subject to change as new evidence emerges and existing guidelines are updated. Recommendations on patient care are not absolute. Final decisions remain under the discretion of the healthcare provider.
As the unified algorithms are utilized, end-users are enjoined to provide feedback as to their experience with use of the algorithms in the field through: secretariat@psmid.org and hpaac.org.ph/contact or secretariat@hpaac.org.ph.
The following organizations and their representatives contributed to the content, review and update of various sections:
Version 1 and 2 Contributors
You may download the most recent Unified COVID-19 Algorithms here (Document date: February 21, 2022).
The Unified COVID-19 Algorithms are based primarily on the latest Philippine COVID-19 Living Recommendations as well as other relevant guidelines and circulars. As such, the recommendations will be constantly updated, and new recommendations will be added as the evidence evolves. The recommendations are based on the best evidence available in scientific literature at the time of its formulation. The unified algorithms and the living recommendations are not comprehensive guides to all practice questions and management options on COVID-19. The algorithms and guidelines are not meant to restrict the practitioner in using sound clinical judgement and sharing the decision with the patient, and from considering other management options according to the patient’s particular needs and preferences. The said algorithms and guidelines can also serve to inform policy, but they are not meant to serve as basis for approving or denying financial coverage or insurance claims merely because of nonconformance with recommendations. Neither are the recommendations intended to be considered as legal rules for dictating certain modes of action to the exclusion of others.
Calling all adolescents ages 12-17 and their parents!
We want to know your thoughts on COVID-19 vaccination for adolescents.
You may scan this QR code or go to the provided link to answer our survey: bit.ly/CovidVaccineSurvey_Main
Dr. Jemelyn Garcia, FPCP, FPSMID
Dr. Maria Sonia Salamat, FPCP, FPSMID
Dr. Marja B. Buensalido, FPCP, FPSMID
Dr. Emmerson Gale Vista, FPDS
Dr. Clarisse Garcia-Mendoza, FPDS
Dr. Kingbherly L. Li, FPCP, FPSMID
Dr. Yvette Silubrico, FPCP, FPSMID
Dr. Chatie Olasiman, FPCP, FPSMID
Dr. Ma. Charmian Hufano, FPCP, FPSMID
Dr. Mitzie Lou Osabel, FPCP, FPSMID
Dr. Janice C. Caoili, FPCP, FPSMID
The Philippine Society for Microbiology and Infectious Diseases (PSMID) Guidance on the Management of Mpox, Ver. 1 provides the basic and most updated information on management of patients confirmed with mpox.
This guidance complements the mpox recommendations of the DOH (Updated Interim Guidelines on the Prevention, Detection, and Management of MPOX, by Department of Health, August 26, 2024, Department Memorandum 2024-0306) and PHICS-PHICNA (Interim Guidelines on the Prevention and Control of Monkeypox version 1).
The antivirals, immunoglobulin and vaccines discussed below are not available locally. In our local situation, we should maximize supportive care for mpox cases.